These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9785702

  • 1. The Canadian experience with risperidone for the treatment of schizophrenia: an overview.
    Iskedjian M, Hux M, Remington GJ.
    J Psychiatry Neurosci; 1998 Sep; 23(4):229-39. PubMed ID: 9785702
    [Abstract] [Full Text] [Related]

  • 2. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C, Dusouchet T, Bret P, Queuille E, Biscay ML, Caron J, Bret MC.
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [Abstract] [Full Text] [Related]

  • 3. Risperidone in acute and long-term therapy of schizophrenia--a clinical profile.
    Pajonk FG.
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):15-23. PubMed ID: 14687852
    [Abstract] [Full Text] [Related]

  • 4. An open, randomized, comparative study of efficacy and safety of risperidone and haloperidol in schizophrenia.
    Tamrakar SM, Nepal MK, Koirala NR, Sharma VD, Gurung CK, Adhikari SR.
    Kathmandu Univ Med J (KUMJ); 2006 Jan; 4(2):152-60. PubMed ID: 18603890
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Selection of atypical antipsychotics for the management of schizophrenia.
    Sprague DA, Loewen PS, Raymond CB.
    Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
    [Abstract] [Full Text] [Related]

  • 7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Clinical experience and management considerations with long-acting risperidone.
    Parellada E.
    Curr Med Res Opin; 2006 Feb; 22(2):241-55. PubMed ID: 16466596
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K, Carlsson A, Stening G.
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [Abstract] [Full Text] [Related]

  • 12. Novel pharmacological approaches to the treatment of schizophrenia.
    Fink-Jensen A.
    Dan Med Bull; 2000 Jun; 47(3):151-67. PubMed ID: 10913983
    [Abstract] [Full Text] [Related]

  • 13. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [3 years of clinical experience with risperidone: new therapeutic standards in the management of schizophrenia].
    Nervenarzt; 1996 Oct; 67(10 Suppl Neue Thera):1-4. PubMed ID: 9403092
    [No Abstract] [Full Text] [Related]

  • 16. [Schizophrenia and quality of life--new definition of therapeutic targets].
    Fortschr Neurol Psychiatr; 1997 Nov; 65(11 Suppl Schizophre):1-4. PubMed ID: 9431352
    [No Abstract] [Full Text] [Related]

  • 17. Pregabalin Adjuventia Helped Risperidone-Induced Extrapyramidal Syndrome and Augmented Antipsychotic Response in an Adolescent with Schizophrenia.
    Naguy A, Pridmore S, Alamiri B.
    Psychopharmacol Bull; 2024 Mar 04; 54(1):40-42. PubMed ID: 38449476
    [Abstract] [Full Text] [Related]

  • 18. Hyperprolactinaemia induced by risperidone.
    Chung YC, Eun HB.
    Int J Neuropsychopharmacol; 1998 Jul 04; 1(1):93-94. PubMed ID: 11281951
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Risperidone induced angioedema with concurrent EPS symptoms: a case report and review of literature.
    Samra GS, Kant S, Chow R.
    J Community Hosp Intern Med Perspect; 2018 Jul 04; 8(2):80-83. PubMed ID: 29686794
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.